EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Redefining Malignant Hyperthermia: Multi-Omics Insights into a Complex Anesthetic Disorder

Cassandra Thachuk, Darragh Barry, Jackie Trink

Lifestyle Genomics · 25.09.2025 · 19 (1) · 76-82

DOI: 10.1159/000548601 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Lifestyle Genomics, online erschienen am 25.09.2025. Verfasst von Cassandra Thachuk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Limerick, Limerick, Ireland, cassandrathachuk@hotmail.ca. Hauptthemen laut MEDLINE: Malignant Hyperthermia, Anesthetics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Malignant hyperthermia (MH) is a rare but serious pharmacogenetic disorder triggered by specific anesthetic agents, leading to a rapid and often fatal hypermetabolic response. While its genetic roots – primarily involving RYR1 and CACNA1S mutations – are well documented, many susceptible individuals remain undiagnosed until they are exposed to the triggering anesthetic. Despite dantrolene being an instrumental drug in combatting MH mortality, global access remains inconsistent, and morbidity rates remains high. Current diagnostic tools are invasive and limited to specialized centers, and routine screening is rarely feasible. Summary: This review explores how recent advances in multi-omics – genomics, proteomics, metabolomics, transcriptomics, and radiomics – are reshaping our understanding of MH pathophysiology. From chronic calcium dysregulation and mitochondrial dysfunction to shifts in energy metabolism and subtle muscle changes, a complex picture is emerging. Integrative analyses reveal promising biomarkers for early detection, while CRISPR-based gene editing and machine learning offer potential pathways for future targeted interventions. Noninvasive imaging, blood-based metabolic profiling, and genomic risk prediction may soon offer safer, more effective screening tools for anesthesia planning. Key Messages: Ultimately, a shift from reactive crisis management to proactive risk identification could redefine how we approach MH – potentially improving patient outcomes and saving lives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malignant HyperthermiaAnestheticsHumansProteomicsRyanodine Receptor Calcium Release ChannelMetabolomicsGenomicsDantroleneMultiomicsCalcium Channels, L-Type

Stichwörter der Autor:innen

AnesthesiaCACNA1SMalignant hyperthermiaMulti-omicsRYR1

Substanzen

Ryanodine Receptor Calcium Release ChannelAnestheticsDantroleneRYR1 protein, humanCACNA1S protein, humanCalcium Channels, L-Type

Autor:innen und Institutionen

  • Department of Medicine, University of Limerick, Limerick, Ireland, cassandrathachuk@hotmail.ca.
  • Department of Medicine, University of Limerick, Limerick, Ireland.
  • Department of Medical Sciences, McMaster University, Hamilton, Ontario, Canada.

Zitieren

APA

Thachuk, C., Barry, D., & Trink, J. (2025). Redefining Malignant Hyperthermia: Multi-Omics Insights into a Complex Anesthetic Disorder. Lifestyle Genomics, 19(1), 76-82. https://doi.org/10.1159/000548601

Vancouver

Thachuk C, Barry D, Trink J. Redefining Malignant Hyperthermia: Multi-Omics Insights into a Complex Anesthetic Disorder. Lifestyle Genomics. 2025;19(1):76-82. doi:10.1159/000548601

BibTeX
@article{Thachuk2025,
  author = {Thachuk, Cassandra and Barry, Darragh and Trink, Jackie},
  title = {Redefining Malignant Hyperthermia: Multi-Omics Insights into a Complex Anesthetic Disorder},
  journal = {Lifestyle Genomics},
  year = {2025},
  volume = {19},
  number = {1},
  pages = {76--82},
  doi = {10.1159/000548601}
}
Kostenlos starten →